Clearly, Ley epitopes are both expressed in tumors at relatively high surface densities and are aberrantly expressed on various membrane-bound glycoproteins including epidermal growth factor receptors, which are also candidate antigens for tumor immunotherapy [48]–[53]. The gene discussed is EGFR; the disease is neoplasm.